Controlled Substances Regulations Flashcards
7 cards from real MPJE practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Controlled Substances Regulations flashcards as text
Which of the following is a TRUE statement about transferring a Schedule III–V prescription between pharmacies?
Answer: A Schedule III–V prescription may be transferred only once, unless the pharmacies share a real-time electronic database
Federal law allows one transfer of a Schedule III–V prescription between pharmacies, but pharmacies sharing a real-time database may transfer it up to the refill limit.
Under the Controlled Substances Act, which entity has primary authority to schedule, reschedule, or deschedule a controlled substance?
Answer: The DEA, with input from HHS/FDA
The DEA Administrator, after receiving a scientific and medical evaluation from HHS/FDA, has the authority to schedule, reschedule, or deschedule substances.
A practitioner who is DEA-registered to prescribe controlled substances moves to a new office location within the same state. What must the practitioner do?
Answer: Submit DEA Form 224a to modify the registration and may continue prescribing during processing
A practitioner must notify the DEA of an address change using the appropriate form and may continue prescribing while the modification is processed.
Under 21 CFR Part 1306, which of the following is NOT a required element on a valid controlled substance prescription?
Answer: Patient's date of birth
Federal law does not require a patient's date of birth on a controlled substance prescription, although some states do require it.
A nurse practitioner in a state that grants full prescriptive authority wishes to prescribe Schedule II controlled substances. Which DEA form must be submitted to obtain registration?
Answer: DEA Form 224
Individual practitioners—including nurse practitioners—apply for DEA registration using DEA Form 224.
When a controlled substance is administered to a patient in a hospital setting, the record must be maintained for how many years under federal DEA regulations?
Answer: 2 years
DEA regulations require controlled substance records, including administration records, to be maintained for at least 2 years.
Which action is required when a pharmacy discovers an unresolvable discrepancy between the perpetual inventory record and the actual count of a Schedule II drug?
Answer: Report the discrepancy to the DEA as a theft or significant loss using DEA Form 106
An unresolvable discrepancy for a Schedule II drug is considered a significant loss and must be reported to the DEA on Form 106.